Arlene Naranjo
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Cancer therapeutics and mechanisms, Lung Cancer Research Studies, Adrenal and Paraganglionic Tumors
Most-Cited Works
- → Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations(2015)548 cited
- → Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group(2021)451 cited
- → Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma(2019)346 cited
- → Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial(2017)270 cited
- → Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group(2013)207 cited
- → Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032(2021)203 cited
- → Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study(2009)195 cited
- → A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants(2012)193 cited
- → Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group(2020)184 cited
- → Children's Oncology Group's 2013 blueprint for research: Renal tumors(2012)183 cited